Uncomplicated Urinary Tract Infection Treatment Market

Uncomplicated urinary tract infection treatment sales will expand through 2035, with nitrofuran (nitrofurantoin) at 35% of drug class sales and retail pharmacies at 60% within the distribution channel segment in 2025. The market was valued at USD 7.7 billion in 2025 and is forecast to record a 4.4% CAGR between 2025 and 2035.